Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients

International Clinical Psychopharmacology

Volumn 12, Issue 4, 1997, Pages 225-229

  Yasui, N ^a,b   Otani, K ^c   Kaneko, S ^a   Shimoyama, R ^a   Ohkubo, T ^a   Sugawara, K ^a  

^a HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^b Sakurada Hospital   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Carbamazepine; Clarithromycin; CYP3A4; Interaction; Metabolism; Plasma concentration; Toxicity

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLARITHROMYCIN;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; DROWSINESS; DRUG BLOOD LEVEL; DRUG INTERACTION; DRUG METABOLISM; FEMALE; HUMAN; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; VERTIGO;

EID: 0030823858     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199707000-00007     Document Type: Article

References (21)

1. Albani F, Riva R and Baruzzi A (1993) Clarithromycin-carhamazepine interaction: a case report. Epilepsia, 34, 161-162.
2. Albani F, Riva R and Baruzzi A (1995) Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry, 28, 235-244.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). American Psychiatric Association, Washington.
4. Bertilsson L and Tomson T (1986) Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide: an update. Clinical Pharmacokinetics, 11, 177-198.
5. Carranco E, Kareus J, Co S, Peak V and Al-Rajeh S (1985) Carbamazepine toxicity induced by concurrent erythromycin therapy. Archives of Neurology, 42, 187-188.
6. Hamory BH (1989) Viral, mycoplasmal, and atypical infections of the lung. In: Concise Textbook of Pulmonary Medicine (Ed. SR Braun), pp. 216-237. Elsevier, New York.
7. Hedrick R, Williams F, Morin R, Lamb WA and Cate IVJC (1983) Carbamazepine-erythromycin interaction leading to carbamazepine toxicity in tour epileptic children. Therapeutic Drug Monitoring, 5, 405-407.
8. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ and Levy RH (1994) Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11 epoxide formation. Biochemical Pharmacology, 47, 1969-1979.
9. Mesdjian E, Dravet C, Cenraud B and Roger J (1980) Carbamazepine intoxication due to triacethyloleandomycin administration in epileptic patients. Epilepsia, 21, 489-496.
10. Metz DC and Getz HD (1995) Helicobacter pylori gastritis therapy with omeprazole and clarithromycin increases serum carbamazepine levels. Digestive Diseases and Sciences, 40, 912-915.
11. O'Connor NK and Fris J (1994) Clarithromycin-carbamazepine interaction in a clinical setting. Journal of the American Board Family Practice, 7, 489-492.
12. Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg JJ and Neuvonen PJ (1993) A potentially hazardous interaction between erythromycin and midazolam. Clinical Pharmacology and Therapeutics, 53, 298-305.
13. Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T and Sugawara K (1996) Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression. International Clinical Psychoparmacology, 11, 55-57.
14. Periti P, Mazzei T, Mini E and Novelli A (1992) Pharmacokinetic drug interactions of macrolides. Clinical Pharmacokinetics, 23, 106-131.
15. Phillips JP, Antal EJ and Smith RB (1986) A pharmacokinetic drug interaction between erythromycin and triazolam. Journal of Clinical Psychopharmacology, 6, 297-299.
16. Stafstrom CE, Nohria V, Loganbill H, Nahouraii R, Boustany RM and DeLong GR (1995) Erythromycin-induced carbamazepine toxicity: a continuing problem. Archives of Pediatrics and Adolescent Medicine, 149, 99-101.
17. Warot D, Bergougnan L, Lamiable D, Berlin I, Bensimon G, Danjou P and Puech AJ (1987) Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation. European Journal of Clinical Pharmacology, 32, 389-393.
18. Watkins PB (1994) Noninvasive tests of CYP3A enzymes. Pharmacogenetics, 4, 171-184.
19. Yasui N, Otani K, Kaneko S, Ohkubo T, Osanai T, Sugawara K, Chiba K and Ishizaki T (1996) A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Clinical Pharmacology and Therapeutics, 59, 514-519.
20. Yeates RA, Laufen H and Zimmermann T (1996) Interaction between midazolam and clarithromycin: comparison with azithromycin. International Journal of Clinical Pharmacology and Therapeutics, 34, 400-405.
21. Zuckerman JM and Kaye KM (1995) The newer macrolides: azithromycin and clarithromycin. Infectious Disease Clinics of North America, 9, 731-745.